Jason Andrews, MD, SM, DTM&H Division of Infectious Diseases Massachusetts General Hospital Harvard Medical School International AIDS Society July 2, 2013.

Slides:



Advertisements
Similar presentations
Contact Evaluation Your name Institution/organization Meeting Date International Standard 16.
Advertisements

Contact Evaluation Your name Institution/organization Meeting Date International Standards 18, 19.
What is Epidemiology? (1)
Disease emergence in immunocompromised populations Jamie Lloyd-Smith Penn State University.
Impact of Age and Race on New HIV Infections among Men who have Sex with Men in Los Angeles County Shoshanna Nakelsky, MPH Division of HIV and.
How can Modeling Help in Emerging Epidemics? John Grefenstette, PhD Public Health Dynamics Lab Health Policy & Management Pitt Public Health Dec 5, 2014.
Jason R. Andrews, MD Stephen D. Lawn, MD, DTM&H Corina Rusu, BA, BS Robin Wood, FCP, MMed, DTM&H Farzad Noubary, PhD Melissa A. Bender, MD, MPH Robert.
Atrial Fibrillation in Patients with Cryptogenic Stroke Gladstone DJ et al. N Engl J Med 2014; 370: Presented by Kris Huston | July 21, 2014.
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
Mary Foote MD, MPH 1 Infectious Disease Fellow Anne Spaulding MD, MPH 1,2 1 Emory University Schools of Medicine and 2 Public Health Atlanta, Georgia Georgia.
Epidemiology and Public Health Introduction, Part II.
Evaluating Whether Interventions on the Use of Antibiotics Work to Decrease Resistance Chris Ford Regina Joice 1/18/08.
The ninth Technical Advisory Group and National TB Managers meeting
Standard of Care for MDR-TB
Southern Africa out of control Swaziland South Africa Namibia Botswana Zimbabwe Lesotho Zambia
[ Routine BCG vaccination to newborns- Future challenges Prof. Fahad Abdullah Al Zamil Professor and Consultant, Pediatric Infectious Diseases Head of.
Reduced treatment delays for drug-resistant TB/HIV co-infected patients with decentralised care and rapid Xpert MTB/Rif test in Khayelitsha, South Africa.
HIV Screening and Care: Clinical Outcomes, Transmission and Cost A. David Paltiel, PhD Yale University School of Medicine May 9, 2007 National Institute.
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
1 TB/HIV Project in the Philippines Yumiko Yanase.
Indianapolis Discovery Network for Dementia Forecasting the Future Impact of Early Detection and Management Program for Alzheimer.
Modelling the role of household versus community transmission of TB in Zimbabwe Georgie Hughes Supervisor: Dr Christine Currie (University of Southampton)
Use of Network Analysis During a Tuberculosis Investigation Outbreak Investigation Section Surveillance and Epidemiology Branch Division of Tuberculosis.
IGRAs in Practice: The San Francisco Health Department Experience Jennifer Grinsdale, MPH Program Manager/Epidemiologist Acting Director Tuberculosis Control.
© 2005, Johns Hopkins University. All rights reserved. Department of Health, Behavior & Society David Holtgrave, PhD, Professor & Chair.
EPIB-591 Screening Jean-François Boivin 29 September
Challenges of service integration: the TB model Linda-Gail Bekker The Desmond Tutu HIV Centre, Faculty of Health Sciences, University of Cape Town, South.
Johns Hopkins Center for Tuberculosis Research
COST-BENEFIT OF INTEGRATING CRYPTOCOCCAL ANTIGEN SCREENING AND PREEMPTIVE TREATMENT INTO ROUTINE HIV CARE Radha Rajasingham, David Meya, Melissa Rolfes,
Using HIV Surveillance to Achieve High Impact Prevention Irene Hall, PhD, FACE AIDS 2012 High-Impact Prevention: Reducing the HIV Epidemic in the United.
Sanghyuk Shin, PhD Department of Epidemiology UCLA Fielding School of Public Health Aug 27, 2015 Tuberculosis and HIV Co-infection: “A Deadly Syndemic”
Modelling infectious diseases Jean-François Boivin 25 October
ROLE OF HAND HYGIENE IN PREVENTING TRANSMISSION OF INFECTIOUS DISEASES David Jay Weber, M.D., M.P.H. Medical Director, Hospital Epidemiology Professor.
1 st International Treatment as Prevention (TasP) Workshop Overview British Columbia Centre for Excellence in HIV/AIDS Julio Montaner MD, DSc(hon), FRCPC,
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
Exploring the potential impact of ART in reducing HIV transmission. Geoff Garnett, Jeff Eaton, Tim Hallett & Ide Cremin Imperial College London.
RATES AND RISK Daniel E. Ford, MD, MPH Johns Hopkins School of Medicine Introduction to Clinical Research July 12, 2010.
Epidemiology Foundation Standard 3
Stefan Ma1, Marc Lipsitch2 1Epidemiology & Disease Control Division
Maria N. Gamaletsou 1,2, David Denning 1, and Nikolaos V. Sipsas 2 1 The National Aspergillosis Centre, University Hospital of South Manchester and The.
INFECTIOUS DISEASE EPIDEMIOLOGY Instructors: Iman Ramadan, MD King Abdulaziz University Mary C. Smith Fawzi, ScD Harvard University.
Screening and its Useful Tools Thomas Songer, PhD Basic Epidemiology South Asian Cardiovascular Research Methodology Workshop.
Natural History & Spectrum of Diseases
ARV-Based Prevention: Perspective from Epidemiology & Modelling Tim Hallett Imperial College London.
A Community HCT model for Integrated HIV and TB testing in Cape Town, South Africa. Presented by: Sue-Ann Meehan 20 July 2011.
Do we need to test for isoniazid resistance? No conflict of interest Claudia Denkinger, MD PhD McGill University, Montreal Foundation for Innovative New.
Natural History & Spectrum of Diseases
Tuberculosis in Children and Young Adults
Timothy Wiemken, PhD MPH Assistant Professor Division of Infectious Diseases Diagnostic Tests.
1 Preparedness for an Emerging Infection Niels G Becker National Centre for Epidemiology and Population Health Australian National University This presentation.
CT Screening for Lung Cancer vs. Smoking Cessation: A Cost-Effectiveness Analysis Pamela M. McMahon, PhD; Chung Yin Kong, PhD; Bruce E. Johnson; Milton.
Health system design priority IS questions Margaret E. Kruk, MD, MPH Associate Professor of Global Health Harvard T.H. Chan School of Public Health.
Universal Opt-Out Screening for HIV in Health Care Settings, Cost Effectiveness in Action Douglas K. Owens, MD, MS VA Palo Alto Health Care System and.
NAAT identified chlamydial infections: Enhanced sensitivity, reduced transmissibility? Presenter: Maria Villarroel, MA Authors: Maria A. Villarroel, MA.
TB PREVENTION by Assoc. Prof. Dr. Nik Sherina Haidi Hanafi 1.
ZAMSTAR restricted randomisation CREATE Investigators Meeting 2005 Charalambos (Babis) Sismanidis LSHTM.
Screening Tests: A Review. Learning Objectives: 1.Understand the role of screening in the secondary prevention of disease. 2.Recognize the characteristics.
Increasing Tuberculosis Prevalence in South African Township Associated With Increasing HIV Prevalence Slideset on: Lawn SD, Bekker LG, Middelkoop K, Myer.
Chlamydia screening programs: are epidemiology and mathematical modelling looking at the same thing? Nicola Low Institute of Social and Preventive Medicine.
Participants 18year old+
The intersection between diabetes and tuberculosis: a perspective
Modelling infectious diseases
CDC Guidelines for Use of QuantiFERON®-TB Gold Test
Evidence for use of urinary LAM
Epidemiological Modeling to Guide Efficacy Study Design Evaluating Vaccines to Prevent Emerging Diseases An Vandebosch, PhD Joint Statistical meetings,
Tuberculosis Global Epidemiology
C R E A E Consortium to Respond Effectively to the AIDS-TB Epidemic
Surveillance for TB in HIV Care and Treatment Settings (CTS)
Susceptible, Infected, Recovered: the SIR Model of an Epidemic
THE 49TH UNION WORLD CONFERENCE ON LUNG HEALTH
Presentation transcript:

Jason Andrews, MD, SM, DTM&H Division of Infectious Diseases Massachusetts General Hospital Harvard Medical School International AIDS Society July 2, 2013 Intensified case finding in the era of new diagnostics: what is the impact?

Introduction: Active Case Finding (ACF) There are good data on yield of ACF for TB via community-based case finding or household contact investigations Meta-analysis of 27 studies: 4.5% HH contacts had active TB Shapiro et al. found at least one TB case in 19% of HHs where an index case had been found and 1% of random households visited in South Africa Fewer data on the individual level clinical benefits of early case detection. Even more limited evidence base (DETECTB, ZAMSTAR) on population level epidemiologic impact of ACF interventions Morrison et al., Lancet Infect Dis 2008 Shapiro et al., AJRCCM 2012

What can mathematical models tell us about the benefits of active case finding for TB? Not much… in quantitative terms. Limitations in understanding of: 1.Infectiousness over time 2.Duration of subclinical tuberculosis 3.Role of social contact structure

Overview 1.Explain critical assumptions and limitations of TB diagnostic models 2.How these assumptions impact projections for community-based ACF and household contact investigations 3.What we need to make better projections

Examining these assumptions: impact on ACF

Dowdy DW, Basu S, Andrews JR. Am J Resp Crit Care Med, 2012 Passive CFActive CF

Model and Results If individuals are asymptomatic (“subclinical”, and only 0.25x as infectious) for half of their duration of TB: - 20% increase in passive diagnosis would reduce TB incidence by 11% over 10 years - ACF targeted at 5% of population would reduce TB incidence by 16% over 10 years As duration/infectiousness subclinical period increases, efficacy of passive case detection decreases ACF needed if much of transmission occurs during a subclinical period

Dowdy DW, Basu S, Andrews JR. Am J Resp Crit Care Med, 2012 ? ?

Examining these assumptions: household contact investigations

Household Infectious Exposed Susceptible

Household Infectious Exposed Susceptible

Household Infectious Exposed Susceptible

Household Infectious Exposed Susceptible

Household Infectious Exposed Susceptible

Household Contacts Created a simple model, governed by ordinary differential equations, with two levels of transmission: within and between households Calibrated it to TB prevalence of 170/100,000 Varied proportion of TB transmitted within the household versus within the community** Projected the impact of: 1) HH contact investigations for active TB; 2) HH contact investigations + LTBI treatment Assumed 100% coverage of intervention and “perfect” sensitivity of diagnostic testing

Cape Town

Conclusions We have poor data on role of subclinical TB in transmission, which is critical to projecting the impact of passive and active case finding approaches Epidemiologic impact of household contact investigations is somewhat attenuated due to mutual contacts between the index and secondary case Data on within-household versus between- household transmission could improve quantitative projections on contact investigation interventions

Acknowledgements Robin Wood, FCP(SA), DSc – University of Cape Town Rochelle Walensky, MD, MPH – MGH/Harvard David Dowdy, MD, PhD – Johns Hopkins Sanjay Basu, MD, PhD – Stanford Megan Murray, MD, ScD - Harvard